Does TOFACITINIB Cause Non-hodgkin's lymphoma? 263 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 263 reports of Non-hodgkin's lymphoma have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.2% of all adverse event reports for TOFACITINIB.
263
Reports of Non-hodgkin's lymphoma with TOFACITINIB
0.2%
of all TOFACITINIB reports
7
Deaths
14
Hospitalizations
How Dangerous Is Non-hodgkin's lymphoma From TOFACITINIB?
Of the 263 reports, 7 (2.7%) resulted in death, 14 (5.3%) required hospitalization, and 1 (0.4%) were considered life-threatening.
Is Non-hodgkin's lymphoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 263 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Non-hodgkin's lymphoma?
RANITIDINE (983)
RITUXIMAB (653)
METHOTREXATE (512)
ADALIMUMAB (498)
ETANERCEPT (468)
AZATHIOPRINE (407)
SULFASALAZINE (357)
HYDROXYCHLOROQUINE (348)
LEFLUNOMIDE (327)
MINOCYCLINE (298)
Which TOFACITINIB Alternatives Have Lower Non-hodgkin's lymphoma Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN